EE414 Incremental Costs of Abrocitinib Compared to Dupilumab for the Treatment of Moderate to Severe Atopic Dermatitis in Denmark
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.680
https://www.valueinhealthjournal.com/article/S1098-3015(23)03810-X/fulltext
Title :
EE414 Incremental Costs of Abrocitinib Compared to Dupilumab for the Treatment of Moderate to Severe Atopic Dermatitis in Denmark
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03810-X&doi=10.1016/j.jval.2023.09.680
First page :
Section Title :
Open access? :
No
Section Order :
10166